A phase II study of sequential carboplatin (C), paclitaxel (P) and topetecan (T) in patients with previously untreated advanced ovarian cancer

被引：0
|
作者：
Agarwal, R
Seckl, MJ
Nelstrop, A
Rustin, GJS
机构：
[1] Charing Cross Hosp, Dept Med Oncol, London W6 8RF, England
[2] Mt Vernon Hosp, Northwood HA6 2RN, Middx, England
来源：
BRITISH JOURNAL OF CANCER | 1999年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P315
引用
收藏
页码：107 / 107
页数：1
相关论文
共 50 条
  • [41] A phase I/II dose escalation study of carboplatin in the treatment of newly diagnosed patients with advanced ovarian cancer receiving paclitaxel
    Gordon, AN
    Hancock, KC
    Matthews, CM
    Stringer, A
    Boston, J
    Nemunaitis, J
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1999, 22 (06): : 601 - 605
  • [42] Phase I/II study of the combination of carboplatin and paclitaxel as first-line chemotherapy in patients with advanced epithelial ovarian cancer
    duBois, A
    Luck, HJ
    Bauknecht, T
    Mobus, V
    Bochtler, H
    Diergarten, K
    Meerpohl, HG
    ANNALS OF ONCOLOGY, 1997, 8 (04) : 355 - 361
  • [43] Paclitaxel in cisplatin or carboplatin-pretreated ovarian cancer - Phase II study
    Pectasides, D
    Papadopoulou, M
    Varthalitis, J
    Mylonakis, A
    Kostopoulou, M
    Dimitriadis, M
    Athanassiou, A
    ONCOLOGY, 1998, 55 (03) : 228 - 234
  • [44] Phase II study of combination paclitaxel and carboplatin in patients with advanced or recurrent endometrial cancer.
    Shan, B.
    Wang, H.
    Ren, Y.
    Tu, X.
    Jiang, Z.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [45] Carboplatin in combination with epirubicin and cyclophosphamide in patients with advanced ovarian cancer - a phase II study
    Acta Oncol, 6 (821):
  • [46] Phase Ib study of metformin in combination with carboplatin/paclitaxel chemotherapy in patients with advanced epithelial ovarian cancer
    Broekman, K. E.
    Reyners, A. K. L.
    Touw, D. J.
    Hof, M. A. J.
    Jalving, M.
    ANNALS OF ONCOLOGY, 2018, 29 : 354 - 354
  • [47] Phase I study of metformin in combination with carboplatin/paclitaxel chemotherapy in patients with advanced epithelial ovarian cancer
    K. Esther Broekman
    Marieke A. J. Hof
    Daan J. Touw
    Jourik A. Gietema
    Hans W. Nijman
    Joop D. Lefrandt
    An K. L. Reyners
    Mathilde Jalving
    Investigational New Drugs, 2020, 38 : 1454 - 1462
  • [48] Phase I study of metformin in combination with carboplatin/paclitaxel chemotherapy in patients with advanced epithelial ovarian cancer
    Broekman, K. Esther
    Hof, Marieke A. J.
    Touw, Daan J.
    Gietema, Jourik A.
    Nijman, Hans W.
    Lefrandt, Joop D.
    Reyners, An K. L.
    Jalving, Mathilde
    INVESTIGATIONAL NEW DRUGS, 2020, 38 (05) : 1454 - 1462
  • [49] Carboplatin and paclitaxel in patients with advanced ovarian cancer: A dose-finding study
    Huinink, WT
    Veenhof, C
    Huizing, M
    Rodenhuis, S
    Helmerhorst, T
    Dubbelman, R
    Dalesio, O
    Beijnen, J
    Winograd, B
    SEMINARS IN ONCOLOGY, 1997, 24 (01) : S31 - S33
  • [50] A RANDOMIZED PHASE II STUDY EVALUATING THE ACTIVITY OF BEVACIZUMAB IN COMBINATION WITH CARBOPLATIN PLUS PACLITAXEL IN PATIENTS WITH PREVIOUSLY UNTREATED ADVANCED MUCOSAL MELANOMA (NCT02023710)
    Sheng, Xinan
    Si, Lu
    Chi, Zhihong
    Cui, Chuanliang
    Li, Siming
    Mao, Lili
    Lian, Bin
    Tang, Bixia
    Yan, Xieqiao
    Wang, Xuan
    Kong, Yong
    Dai, Jie
    Zhang, Xiao S.
    Song, Xicheng
    Guol, Jun
    ANTICANCER RESEARCH, 2015, 35 (07) : 4350 - 4350
12345